Antioxidant enzymes, inflammatory indices and lifestyle factors in older men: A cohort analysis

QJM: An International Journal of Medicine

Volumn 92, Issue 10, 1999, Pages 579-585

  Mulholland, C W ^a   Elwood, P C ^b   Davis, A ^b   Thurnham, D I ^a   Kennedy, O ^a   Coulter, J ^a   Fehily, A ^c   Strain, J J ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ANTIOXIDANT; CERULOPLASMIN; ENZYME; GLUTATHIONE PEROXIDASE; OXIDOREDUCTASE; PROTEIN;

ADULT; AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LIFESTYLE; MALE; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; SMOKING HABIT; SOCIOECONOMICS;

EID: 0032709920     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/92.10.579     Document Type: Article

References (39)

1. World Health Statistics Annual 1994. WHO, Geneva.
2. Halliwell B, Gutteridge JMC. Free Radicals - Biology and Medicine, 2nd edn. Oxford, Clarendon Press, 1989.
3. Steinberg D. Antioxidant vitamins and coronary heart disease. N Engl J Med 1993; 328:1487-9.
4. Janero DR. Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis. Free Rad Biol Med 1991; 11:129-44.
5. Hensrud DD, Heimburger DC, Chen J, Parkia B. Antioxidant status erythrocyte fatty acids and mortality from cardiovascular disease and Keshan disease in China. Eur J Clin Nutr 1994; 48:455-64.
6. Gutteridge JMC, Halliwell B. Antioxidants in Nutrition, Health and Disease. Oxford, Oxford University Press, 1996.
7. McCord JM, Fridovich I. Superoxide dismutase; an enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244:6049-55.
8. Frank L, Massaro D. Oxygen toxicity. Am J Med 1980; 69:117-26.
9. Fridovich I. The biology of oxygen radicals. Science 1978; 201:875-80.
10. Porter M, Pearson DJ, Suarezmendez VJ, Blann AD. Plasma, platelet and erythrocyte glutathione peroxidases as risk factors in ischaemic heart disease in man. Clin Sci 1992; 83:343-5.
11. Chandra M, Chandra N, Agrawal R, Kumar A, Ghatak A, Pandey VC. The free radical system in ischaemic heart disease. Int J Cardiol 1994; 43:121-5.
12. Hill MF, Singal PK. Antioxidant and oxidative stress changes during heart failure subsequent to myocordial infarction in rats. Am J Pathol 1996; 148:291-300.
13. Ji LL, Dillon D, Wu E. Myocardial ageing: antioxidant enzyme systems and related biochemical properties. Am J Physiol 1991; 261:386-92.
14. Duthie, GG, Shortt CT, Robertson JD, Walker KA, Arthur JR. Plasma antioxidants, indexes of lipid peroxidation and coronary heart disease risk factors in a scottish population. Nutr Res 1992; 12:61-7.
15. Buczynski A, Wachowicz B, Kedziorakornatowska K, Tkaczewski W, Kedziora J. Changes in antioxidant enzyme activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease. Atherosclerosis 1993; 100:223-8.
16. Loeper J, Goy, Rozensztazn L, Bedu O, Moisson P. Lipid peroxidation and protective enzymes during myocardial infarction. Clinica Chimica Acta 1991; 196:119-25.
17. Alatas O, Colak O, Inol M, Koken T, Ata N, Unalir A, Cavusoglu Y. Med Sci Res 1996; 24:467-9.
18. Caerphilly and Speedwell collaborative heart disease studies. I Epidemiol Comm Health 1984; 38:259-62.
19. The Caerphilly Collaborative Heart Disease Studies: Project Description and Manual of Operations. MRC Epidemiology Unit, 1985.
20. Frankel S, Elwood P, Sweetman P, Yarnell J, Davey Smith G. Birthweight, body-mass index in middle age, and coronary heart disease. Lancet 1996; 348:1478-80.
21. Sweetman PM, Thomas HF, Yarnell JWG, Beswick AD, Baker IA, Elwood PC. Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease. The Caerphilly and Speedwell Studies. Eur Heart J 1996; 17:1814-20.
22. Aebi H. Catalase. Methods Enzymol 1984; 105:121-6.
23. Dacie JV, Lewis SM. In: Practical Haematology, 5th edn. London, Churchill Livingstone, 1975:30-7.
24. Henry RJ, Chiamori N, Jacobs SL, Segalove M. Determination of caeruloplasmin oxidase in serum. Proc Soc Exp Biol Med 1960; 104:620-4.
25. Yarnell JWC, Fehily AM, Milbank J, Kubicki AJ, Eastham R, Hayes TM, Determinants of plasma lipoproteins and coagulation factors in men from Caerphilly, South Wales. J Epidemiol Comm Health 1983; 37:137-40.
26. Yarnell JWG, Elwood PC, Renaud S. Platelet function and ischaemic heart disease in the Caerphilly study: Preliminary results. Biblthca Nutr Dieta 1987; 40:19-27.
27. O'Neill O, Fehily AM. Nutrient intakes of men in South Wales: a comparison of surveys taken in 1980-1983 and 1990. J Hum Nutr Dietetics 1991; 413-19.
28. Elwood PC, Beswick AD, O'Brien JR. Life-style, dietary and environmental determinants of thrombosis related tests in the Caerphilly Heart Disease Study. Br J Haematol 1994; 86:16.
29. Elwood PC, Hopkinson C, Pickering J. Determinants of cognitive function in the Caerphilly Cohort Study. Eur J Clin Invest 1995; 25: A65.
30. Barnett YA, King CM. Investigations of antioxidant status, DMA-repair capacity and mutation as a function of age in humans. Mutat Res 1995; 338:115-28.
31. Prohaska JR, Oh SH, Hoestra WG, Ganther HE, Glutathione peroxidase: inhibition by cyanide and release of erythrocyte glutathione peroxidase. Biochem Biophys Res Comm 1977; 74:64-71.
32. Lafont A, Marwick TH, Chisolm GM, Vanlente F, Vaska KJ, Whitlow PL. Decreased free radical scavengers with reperfusion after coronary angioplasty in patients with acute myocardial infarction. Am Heart J 1996; 136:219-23.
33. Aebi H, Wyss SR, Scherz B, Skvaril F. Heterogeneity of erythrocyte catalase II. Isolation and characterization of normal and variant erythrocyte catalase and their subunits. Eur J Biochem 1974; 48:137-45.
34. Thompson D, Milford-Ward A, Whicher JT. The value of acute phase proteins in clinical practice. Ann Clin Biochem 1992; 29:123-31.
35. Edmonds LM. Unpublished, personal communication, 1996.
36. Gutteridge JM, Quinlan GJ, Mumby S, Heath A, Evans TW. Primary plasma antioxidants in adult respiratory distress syndrome patients: changes in iron oxidising, iron binding, and free radical scavenging proteins. J Lab Clin Med 1994; 124:263-73.
37. Strain JJ, Thompson KA, Carville DGM, Barker ME, McNulty H, Young P, Rice DA. J Biomed Sci 1992; 2:143-9.
38. Brown KM, Morrice PC, Arthur JR, Duthie GG. Effects of vitamin E supplementation on erythrocyte antioxidant defence mechanisms of smoking and non-smoking men. Clin Sci 1996; 91:107-11.
39. Schmitz G, Hohage H, Ullrich K. Glucose-6-phosphate a key compound in glycogenosis-1 and favism leading to hyperlipaemia or hypolipidaemia. Eur J Paed 1993; 152:77-9.